Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Noteable

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Jp.morgan

And you buckeroo are a frckin idiot.

11 days ago

T.ONC

RE:RE:RE:RE:JP Morgan healthcare conference

I'll stop posting after this revised MOA repost  ....Inhibition of...

11 days ago

T.ONC

RE:RE:RE:JP Morgan healthcare conference

Should read: January 11, 2025 -  Eli Lilly and Company is ...

11 days ago

T.ONC

RE:RE:RE:RE:JP Morgan healthcare conference

January 11, 2025 - Financial Times of England - " Eli Lilly, the world’s...

11 days ago

T.ONC

RE:RE:RE:JP Morgan healthcare conference

Blockage of PI3K/Akt activation increases reovirus synthesis and viral...

11 days ago

T.ONC

RE:RE:JP Morgan healthcare conference

January 11, 2024 -  Eli Lilly and Company is in advanced talks to...

11 days ago

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:More dry powder…

Get real! Canadafan and your following buckeroo are way too old to be anyone...

January 8, 2025

T.ONC

RE:Fun day today…

" fun day" .. Eh Canadafan? Only you would post such a prosaic...

January 8, 2025

T.ONC

RE:Fun day today…

Just like on cue ... Canadafan posts relentlessly and the price goes down...

January 8, 2025

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:More dry powder…

BALONEY 

January 8, 2025

T.ONC

RE:RE:RE:RE:Quiet day today..

So people like Canadafan just shut up.

January 8, 2025

T.ONC

RE:RE:RE:RE:RE:RE:More dry powder…

saltpeterstemper and CMHarring have blown their cover. He inadvertently...

January 8, 2025

T.ONC

RE:RE:RE:RE:RE:RE:CAR-T update

Roche intends to complete the acquisition of Poseida through a merger of Blue...

January 8, 2025

T.ONC

RE:RE:RE:RE:RE:More dry powder…

saltpeterstemper is just another buckeroo troll 

January 8, 2025

T.ONC

RE:RE:RE:Quiet day today..

People here just don't know when to shut up !

January 8, 2025

T.ONC

RE:RE:RE:RE:RE:CAR-T update

January 08, 2025 -  Roche Nears Completion of CAR-T therapy company...

January 8, 2025

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:JP Morgan healthcare conference

ONCY is showing commanding 3 year mOS primary endpoint data in the treatment...

January 6, 2025

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:JP Morgan healthcare conference

There is no doubting that postive 3 year(gold standard) mOS data from ONCY...

January 6, 2025

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:JP Morgan healthcare conference

Synonyms of "influential" are: important, forceful and...

January 6, 2025

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:JP Morgan healthcare conference

ONCY is the only one who knows. And you have to ask them about their use of...

January 6, 2025

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Gemina Laboratories Ltd.

Gemina Laboratories Ltd. C.GLAB

Gemina Laboratories Ltd. is a Canada-based biosensor and diagnostic company with a transformative, patented, proprietary ... view more »